MEGAN DABERKO: Open Payments
NPI 1366900599 · PENDLETON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 15 payments from 7 companies in 2025. Trend: 2023 $282 · 2024 $388 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $66 |
| ABBVIE INC. | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| PFIZER INC. | 2 | $33 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $14 |
Products named: VRAYLAR, Wegovy, Auvelity, Ozempic, FARXIGA, Jornay PM, NURTEC ODT, PREVNAR 20.
Industry payments across IN — which companies pay providers there.
